Six intersection drugs, including staurosporine, dasatinib, OTX015, BMS-536924, Luminespib, and IGF1R, were shown in both the GSE183795 and GSE78229 (Figure 5A) and TCGA-PAAD cohorts (Figure 5B). The gene discussed is IGF1R; the disease is pancreatic adenocarcinoma.